Na+ Channel Regulation by Ca2+/calmodulin and Ca2+/calmodulin-dependent Protein Kinase II in Guinea-pig Ventricular Myocytes
Overview
Authors
Affiliations
Aims: Calmodulin (CaM) regulates Na+ channel gating through binding to an IQ-like motif in the C-terminus. Ca2+/CaM-dependent protein kinase II (CaMKII) regulates Ca2+ handling, and chronic overactivity of CaMKII is associated with left ventricular hypertrophy and dysfunction and lethal arrhythmias. However, the acute effects of Ca2+/CaM and CaMKII on cardiac Na+ channels are not fully understood.
Methods And Results: Purified Na(V)1.5-glutathione-S-transferase fusion peptides were phosphorylated in vitro by CaMKII predominantly on the I-II linker. Whole-cell voltage-clamp was used to measure Na+ current (I(Na)) in isolated guinea-pig ventricular myocytes in the absence or presence of CaM or CaMKII in the pipette solution. CaMKII shifted the voltage dependence of Na+ channel availability by approximately +5 mV, hastened recovery from inactivation, decreased entry into intermediate or slow inactivation, and increased persistent (late) current, but did not change I(Na) decay. These CaMKII-induced changes of Na+ channel gating were completely abolished by a specific CaMKII inhibitor, autocamtide-2-related inhibitory peptide (AIP). Ca2+/CaM alone reproduced the CaMKII-induced changes of I(Na) availability and the fraction of channels undergoing slow inactivation, but did not alter recovery from inactivation or the magnitude of the late current. Furthermore, the CaM-induced changes were also completely abolished by AIP. On the other hand, cAMP-dependent protein kinase A inhibitors did not abolish the CaM/CaMKII-induced alterations of I(Na) function.
Conclusion: Ca2+/CaM and CaMKII have distinct effects on the inactivation phenotype of cardiac Na+ channels. The differences are consistent with CaM-independent effects of CaMKII on cardiac Na+ channel gating.
Knock-in swine model reveals new arrhythmia mechanism in Timothy syndrome.
Boukens B, Verkerk A, Bezzina C Nat Cardiovasc Res. 2024; 3(1):18-20.
PMID: 39195890 DOI: 10.1038/s44161-023-00408-6.
BIOLOGICAL ANTIARRHYTHMICS-SODIUM CHANNEL INTERACTING PROTEINS.
Tomaselli G Trans Am Clin Climatol Assoc. 2023; 133:136-148.
PMID: 37701589 PMC: 10493736.
Zybura A, Sahoo F, Hudmon A, Cummins T Cells. 2022; 11(13).
PMID: 35805192 PMC: 9266207. DOI: 10.3390/cells11132108.
Chakouri N, Rivas S, Roybal D, Yang L, Diaz J, Hsu A Nat Cardiovasc Res. 2022; 1(5):1-13.
PMID: 35662881 PMC: 9161660. DOI: 10.1038/s44161-022-00060-6.
Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?.
Horvath B, Szentandrassy N, Almassy J, Dienes C, Kovacs Z, Nanasi P Pharmaceuticals (Basel). 2022; 15(2).
PMID: 35215342 PMC: 8879921. DOI: 10.3390/ph15020231.